A historical review traces Sjögren disease from its early descriptions to the use of salivary gland ultrasound in diagnosis.
|Articles|June 1, 2004
Supplements and Featured Publications
- Tabloid - Future Goals, Targets, and Treatments of Dyslipidemia
- Volume 10
- Issue 1 Treat
CME/CE Quiz
Advertisement
Articles in this issue
over 22 years ago
Dual pathway inhibition: Attacking cholesterol on two frontsover 22 years ago
Future Goals, Targets, and Treatments of Dyslipidemiaover 22 years ago
Managed Care Commentary:MCOs face new challengesover 22 years ago
Phytosterols may play role in atherosclerosisAdvertisement
Related to this article
These phase 3 EXCALIBER-RRMM findings build on earlier MRD-negative complete response results supporting FDA approval of the iberdomide-based regimen.
Postpartum navigation missed its primary goal but raised postpartum visits and primary care use among Medicaid-insured patients.
Stigma, years-long diagnostic delays, and limited follow-up after a crisis remain hurdles for people with serious mental illness, experts say.
MedHaul’s platform streamlines nonemergency medical transportation, boosting on-time oncology visits, reducing costs, and helping patients reach critical care across underserved regions.
A 39,669-patient French cohort found ustekinumab and IL-23 inhibitors carry the lowest infection risk among biologics.
CMS' rule ending Medicaid and CHIP funding for pediatric sex-rejecting procedures is now in effect.
At a roundtable in Cleveland, kidney experts said IgA nephropathy and FSGS often go unrecognized, calling for EHR flags and better referral channels.
Advertisement
Advertisement
Trending on AJMC
1
Oral JAK Inhibitors Boost Hair Regrowth Odds in Alopecia Areata
2
CMS Rule Ends Medicaid, CHIP Funding for Pediatric Gender Care
3
Panel Calls for Earlier Detection, Clearer Pathways in Rare Glomerular Disease
4
Medicare Drug Price Negotiations Yield Uneven Out-of-Pocket Savings
5